Vivos Therapeutics Statistics
Total Valuation
VVOS has a market cap or net worth of $7.07 million. The enterprise value is $7.43 million.
Market Cap | 7.07M |
Enterprise Value | 7.43M |
Important Dates
The next estimated earnings date is Thursday, June 6, 2024, after market close.
Earnings Date | Jun 6, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
VVOS has 2.73 million shares outstanding. The number of shares has increased by 32.46% in one year.
Shares Outstanding | 2.73M |
Shares Change (YoY) | +32.46% |
Shares Change (QoQ) | +18.58% |
Owned by Insiders (%) | 7.39% |
Owned by Institutions (%) | 13.76% |
Float | 1.93M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.51 |
Forward PS | 0.41 |
PB Ratio | 17.21 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.54 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.34, with a Debt / Equity ratio of 4.85.
Current Ratio | 0.34 |
Quick Ratio | 0.25 |
Debt / Equity | 4.85 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -568.60% and return on invested capital (ROIC) is -718.87%.
Return on Equity (ROE) | -568.60% |
Return on Assets (ROA) | -104.70% |
Return on Capital (ROIC) | -718.87% |
Revenue Per Employee | $121,061 |
Profits Per Employee | -$119,149 |
Employee Count | 114 |
Asset Turnover | 1.06 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.13% in the last 52 weeks. The beta is 7.90, so VVOS's price volatility has been higher than the market average.
Beta (1Y) | 7.90 |
52-Week Price Change | -68.13% |
50-Day Moving Average | 4.06 |
200-Day Moving Average | 6.74 |
Relative Strength Index (RSI) | 32.46 |
Average Volume (30 Days) | 214,437 |
Short Selling Information
The latest short interest is 191,083, so 7.00% of the outstanding shares have been sold short.
Short Interest | 191,083 |
Short Previous Month | 18,686 |
Short % of Shares Out | 7.00% |
Short % of Float | 9.89% |
Short Ratio (days to cover) | 0.50 |
Income Statement
In the last 12 months, VVOS had revenue of $13.80 million and -$13.58 million in losses. Loss per share was -$11.14.
Revenue | 13.80M |
Gross Profit | 8.27M |
Operating Income | -17.30M |
Pretax Income | -13.58M |
Net Income | -13.58M |
EBITDA | -12.96M |
EBIT | -13.58M |
Loss Per Share | -$11.14 |
Balance Sheet
The company has $1.64 million in cash and $2.00 million in debt, giving a net cash position of -$352,000 or -$0.13 per share.
Cash & Cash Equivalents | 1.64M |
Total Debt | 2.00M |
Net Cash | -352,000 |
Net Cash Per Share | -$0.13 |
Equity / Book Value | 411,000 |
Book Value Per Share | 0.15 |
Working Capital | -4.83M |
Cash Flow
In the last 12 months, operating cash flow was -$11.95 million and capital expenditures -$853,000, giving a free cash flow of -$12.80 million.
Operating Cash Flow | -11.95M |
Capital Expenditures | -853,000 |
Free Cash Flow | -12.80M |
FCF Per Share | -$10.50 |
Margins
Gross margin is 59.93%, with operating and profit margins of -125.32% and -98.42%.
Gross Margin | 59.93% |
Operating Margin | -125.32% |
Pretax Margin | -98.42% |
Profit Margin | -98.42% |
EBITDA Margin | -93.92% |
EBIT Margin | -98.42% |
FCF Margin | -92.74% |
Dividends & Yields
VVOS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -32.46% |
Shareholder Yield | -32.46% |
Earnings Yield | -192.01% |
FCF Yield | -180.93% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 27, 2023. It was a reverse split with a ratio of 1:25.
Last Split Date | Oct 27, 2023 |
Split Type | Reverse |
Split Ratio | 1:25 |
Scores
VVOS has an Altman Z-Score of -15.16 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -15.16 |
Piotroski F-Score | 3 |